{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,16]],"date-time":"2026-01-16T00:40:00Z","timestamp":1768524000292,"version":"3.49.0"},"reference-count":39,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000890","name":"National Multiple Sclerosis Society","doi-asserted-by":"publisher","award":["RG150705331"],"award-info":[{"award-number":["RG150705331"]}],"id":[{"id":"10.13039\/100000890","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000065","name":"National Institute of Neurological Disorders and Stroke","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000049","name":"National Institute on Aging","doi-asserted-by":"publisher","award":["NS075527"],"award-info":[{"award-number":["NS075527"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000049","name":"National Institute on Aging","doi-asserted-by":"publisher","award":["NS103988"],"award-info":[{"award-number":["NS103988"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Nuclear Medicine and Biology"],"published-print":{"date-parts":[[2020,9]]},"DOI":"10.1016\/j.nucmedbio.2020.07.007","type":"journal-article","created":{"date-parts":[[2020,7,27]],"date-time":"2020-07-27T13:33:47Z","timestamp":1595856827000},"page":"52-61","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Synthesis and characterization of [125I]TZ6544, a promising radioligand for investigating sphingosine-1-phosphate receptor 2"],"prefix":"10.1016","volume":"88-89","author":[{"given":"Zonghua","family":"Luo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qianwa","family":"Liang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hui","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joshi","family":"Sumit","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hao","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robyn S.","family":"Klein","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhude","family":"Tu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.nucmedbio.2020.07.007_bb0005","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1006\/bbrc.1993.1163","article-title":"Molecular cloning of a novel putative G protein-coupled receptor expressed in the cardiovascular system","volume":"190","author":"Okazaki","year":"1993","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.nucmedbio.2020.07.007_bb0010","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1042\/bj3370067","article-title":"The novel sphingosine 1-phosphate receptor AGR16 is coupled via pertussis toxin-sensitive and -insensitive G-proteins to multiple signalling pathways","volume":"337","author":"Gonda","year":"1999","journal-title":"Biochem J"},{"key":"10.1016\/j.nucmedbio.2020.07.007_bb0015","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.jbior.2015.09.001","article-title":"Role of sphingosine 1-phosphate receptors, sphingosine kinases and sphingosine in cancer and inflammation","volume":"60","author":"Pyne","year":"2016","journal-title":"Adv Biol Regul"},{"key":"10.1016\/j.nucmedbio.2020.07.007_bb0020","doi-asserted-by":"crossref","first-page":"e8","DOI":"10.1016\/j.diabres.2011.06.023","article-title":"Sphingosine-1-phosphate induced vasoconstriction is increased in the isolated perfused kidneys of diabetic rats","volume":"94","author":"Bautista-Perez","year":"2011","journal-title":"Diabetes Res Clin Pract"},{"key":"10.1016\/j.nucmedbio.2020.07.007_bb0025","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2016\/6973175","article-title":"High glucose and lipopolysaccharide prime NLRP3 inflammasome via ROS\/TXNIP pathway in mesangial cells","volume":"2016","author":"Feng","year":"2016","journal-title":"J Diabetes Res"},{"key":"10.1016\/j.nucmedbio.2020.07.007_bb0030","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.etp.2009.02.068","article-title":"Unbalanced expression of sphingosine 1-phosphate receptors in diabetic nephropathy","volume":"62","author":"Imasawa","year":"2010","journal-title":"Exp Toxicol Pathol"},{"key":"10.1016\/j.nucmedbio.2020.07.007_bb0035","doi-asserted-by":"crossref","first-page":"2094","DOI":"10.1210\/me.2011-0095","article-title":"Sphingosine kinase-1 pathway mediates high glucose-induced fibronectin expression in glomerular mesangial cells","volume":"25","author":"Lan","year":"2011","journal-title":"Mol Endocrinol"},{"key":"10.1016\/j.nucmedbio.2020.07.007_bb0040","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.abb.2010.07.012","article-title":"Berberine ameliorates renal injury in diabetic C57BL\/6 mice: involvement of suppression of SphK-S1P signaling pathway","volume":"502","author":"Lan","year":"2010","journal-title":"Arch Biochem Biophys"},{"key":"10.1016\/j.nucmedbio.2020.07.007_bb0045","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1038\/nrm1103","article-title":"Sphingosine-1-phosphate: an enigmatic signalling lipid","volume":"4","author":"Spiegel","year":"2003","journal-title":"Nat Rev Mol Cell Biol"},{"key":"10.1016\/j.nucmedbio.2020.07.007_bb0050","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1038\/nrm2329","article-title":"Principles of bioactive lipid signalling: lessons from sphingolipids","volume":"9","author":"Hannun","year":"2008","journal-title":"Nat Rev Mol Cell Biol"},{"key":"10.1016\/j.nucmedbio.2020.07.007_bb0055","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1016\/j.semcdb.2004.05.002","article-title":"Physiological and pathological actions of sphingosine 1-phosphate","volume":"15","author":"Hla","year":"2004","journal-title":"Semin Cell Dev Biol"},{"key":"10.1016\/j.nucmedbio.2020.07.007_bb0060","doi-asserted-by":"crossref","first-page":"e43874","DOI":"10.1371\/journal.pone.0043874","article-title":"Berberine reduces fibronectin expression by suppressing the S1P-S1P2 receptor pathway in experimental diabetic nephropathy models","volume":"7","author":"Huang","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.nucmedbio.2020.07.007_bb0065","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.bbrc.2010.01.016","article-title":"Blockade of sphingosine 1-phosphate receptor 2 signaling attenuates streptozotocin-induced apoptosis of pancreatic \u03b2-cells","volume":"392","author":"Imasawa","year":"2010","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.nucmedbio.2020.07.007_bb0070","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1152\/jn.00825.2011","article-title":"Sphingosine 1-phosphate receptor 2 antagonist JTE-013 increases the excitability of sensory neurons independently of the receptor","volume":"108","author":"Li","year":"2012","journal-title":"J Neurophysiol"},{"key":"10.1016\/j.nucmedbio.2020.07.007_bb0075","doi-asserted-by":"crossref","first-page":"2571","DOI":"10.1172\/JCI73408","article-title":"Enhanced sphingosine-1-phosphate receptor 2 expression underlies female CNS autoimmunity susceptibility","volume":"124","author":"Cruz-Orengo","year":"2014","journal-title":"J Clin Invest"},{"key":"10.1016\/j.nucmedbio.2020.07.007_bb0080","doi-asserted-by":"crossref","first-page":"5373","DOI":"10.1016\/j.bmc.2013.06.012","article-title":"A sphingosine 1-phosphate receptor 2 selective allosteric agonist","volume":"21","author":"Satsu","year":"2013","journal-title":"Bioorg Med Chem"},{"key":"10.1016\/j.nucmedbio.2020.07.007_bb0085","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1016\/j.bmcl.2015.02.029","article-title":"Discovery of novel S1P2 antagonists. Part 1: discovery of 1,3-bis(aryloxy)benzene derivatives","volume":"25","author":"Kusumi","year":"2015","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1016\/j.nucmedbio.2020.07.007_bb0090","doi-asserted-by":"crossref","first-page":"4387","DOI":"10.1016\/j.bmcl.2015.09.022","article-title":"Discovery of novel S1P2 antagonists. Part 2: improving the profile of a series of 1,3-bis(aryloxy)benzene derivatives","volume":"25","author":"Kusumi","year":"2015","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1016\/j.nucmedbio.2020.07.007_bb0095","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1016\/j.bmcl.2016.01.031","article-title":"Discovery of novel S1P2 antagonists, part 3: improving the oral bioavailability of a series of 1,3-bis(aryloxy)benzene derivatives","volume":"26","author":"Kusumi","year":"2016","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1016\/j.nucmedbio.2020.07.007_bb0100","doi-asserted-by":"crossref","first-page":"167","DOI":"10.3389\/fphar.2016.00167","article-title":"Sphingosine-1-phosphate receptor-2 antagonists: therapeutic potential and potential risks","volume":"7","author":"Blankenbach","year":"2016","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.nucmedbio.2020.07.007_bb0105","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.apradiso.2015.04.010","article-title":"A practical process for the preparation of [32P]S1P and binding assay for S1P receptor ligands","volume":"102","author":"Rosenberg","year":"2015","journal-title":"Appl Radiat Isot"},{"key":"10.1016\/j.nucmedbio.2020.07.007_bb0110","doi-asserted-by":"crossref","first-page":"7928","DOI":"10.1039\/C5OB00951K","article-title":"A potent and selective C-11 labeled PET tracer for imaging sphingosine-1-phosphate receptor 2 in the CNS demonstrates sexually dimorphic expression","volume":"13","author":"Yue","year":"2015","journal-title":"Org Biomol Chem"},{"key":"10.1016\/j.nucmedbio.2020.07.007_bb0115","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1016\/j.bmcl.2017.12.010","article-title":"Design and synthesis of pyrazolopyridine derivatives as sphingosine 1-phosphate receptor 2 ligands","volume":"28","author":"Luo","year":"2018","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1016\/j.nucmedbio.2020.07.007_bb0120","doi-asserted-by":"crossref","first-page":"3619","DOI":"10.1016\/j.bmc.2019.06.047","article-title":"Design, synthesis, and in vitro bioactivity evaluation of fluorine-containing analogues for sphingosine-1-phosphate 2 receptor","volume":"27","author":"Luo","year":"2019","journal-title":"Bioorg Med Chem"},{"key":"10.1016\/j.nucmedbio.2020.07.007_bb0125","doi-asserted-by":"crossref","first-page":"6201","DOI":"10.1021\/acs.jmedchem.6b00390","article-title":"Design, synthesis, and in vitro and in vivo evaluation of an 18F-labeled sphingosine 1-phosphate receptor 1 (S1P1) PET tracer","volume":"59","author":"Rosenberg","year":"2016","journal-title":"J Med Chem"},{"key":"10.1016\/j.nucmedbio.2020.07.007_bb0130","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1007\/s12350-015-0391-1","article-title":"A promising carbon-11-labeled sphingosine-1-phosphate receptor 1-specific PET tracer for imaging vascular injury","volume":"24","author":"Jin","year":"2017","journal-title":"J Nucl Cardiol"},{"key":"10.1016\/j.nucmedbio.2020.07.007_bb0135","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1177\/1536012116689770","article-title":"PET study of sphingosine-1-phosphate receptor 1 expression in response to vascular inflammation in a rat model of carotid injury","volume":"16","author":"Liu","year":"2017","journal-title":"Mol Imaging"},{"key":"10.1016\/j.nucmedbio.2020.07.007_bb0140","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1007\/s11307-017-1141-3","article-title":"Upregulated sphingosine 1-phosphate receptor 1 expression in human and murine atherosclerotic plaques","volume":"20","author":"Liu","year":"2018","journal-title":"Mol Imaging Biol"},{"key":"10.1016\/j.nucmedbio.2020.07.007_bb0145","series-title":"Practical methods in cardiovascular research","first-page":"723","article-title":"Receptor and binding studies","author":"Hein","year":"2005"},{"key":"10.1016\/j.nucmedbio.2020.07.007_bb0150","first-page":"409","article-title":"Synthesis and in vitro characterization of a specific I-125 labeled sphingosine-1-phosphate 2 receptor radioligand [abstract]. In: Society of Nuclear Medicine and Molecular Imaging 2019, Anaheim, California, 22-25 June 2019","volume":"60","author":"Luo","year":"2019","journal-title":"J Nucl Med"},{"key":"10.1016\/j.nucmedbio.2020.07.007_bb0155","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1007\/s00125-007-0886-7","article-title":"The mechanisms of alloxan- and streptozotocin-induced diabetes","volume":"51","author":"Lenzen","year":"2008","journal-title":"Diabetologia"},{"key":"10.1016\/j.nucmedbio.2020.07.007_bb0160","doi-asserted-by":"crossref","first-page":"8054073","DOI":"10.1155\/2018\/8054073","article-title":"Improving the reliability and utility of streptozotocin-induced rat diabetic model","volume":"2018","author":"Wang-Fischer","year":"2018","journal-title":"J Diabetes Res"},{"key":"10.1016\/j.nucmedbio.2020.07.007_bb0165","doi-asserted-by":"crossref","first-page":"2268","DOI":"10.1016\/j.apradiso.2010.06.004","article-title":"Radiosynthesis and biological evaluation of a promising \u03c32-receptor ligand radiolabeled with fluorine-18 or iodine-125 as a PET\/SPECT probe for imaging breast cancer","volume":"68","author":"Tu","year":"2010","journal-title":"Appl Radiat Isot"},{"key":"10.1016\/j.nucmedbio.2020.07.007_bb0170","doi-asserted-by":"crossref","first-page":"1752","DOI":"10.1021\/acs.orglett.8b00232","article-title":"Rapid Cu-catalyzed [211At]astatination and [125I]iodination of boronic esters at room temperature","volume":"20","author":"Reilly","year":"2018","journal-title":"Org Lett"},{"key":"10.1016\/j.nucmedbio.2020.07.007_bb0175","doi-asserted-by":"crossref","first-page":"2005","DOI":"10.1002\/hep.29076","article-title":"The role of sphingosine 1-phosphate receptor 2 in bile-acid-induced cholangiocyte proliferation and cholestasis-induced liver injury in mice","volume":"65","author":"Wang","year":"2017","journal-title":"Hepatology"},{"key":"10.1016\/j.nucmedbio.2020.07.007_bb0180","doi-asserted-by":"crossref","first-page":"2042","DOI":"10.1016\/j.ajpath.2018.05.015","article-title":"Conjugated bile acids promote invasive growth of esophageal adenocarcinoma cells and cancer stem cell expansion via sphingosine 1-phosphate receptor 2-mediated yes-associated protein activation","volume":"188","author":"Liu","year":"2018","journal-title":"Am J Pathol"},{"key":"10.1016\/j.nucmedbio.2020.07.007_bb0185","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1194\/jlr.M800496-JLR200","article-title":"Sphingosine 1-phosphate regulates regeneration and fibrosis after liver injury via sphingosine 1-phosphate receptor 2","volume":"50","author":"Ikeda","year":"2009","journal-title":"J Lipid Res"},{"key":"10.1016\/j.nucmedbio.2020.07.007_bb0190","series-title":"Applied pharmacology","first-page":"17","article-title":"Chapter 2 - pharmacokinetics","author":"Bardal","year":"2011"},{"key":"10.1016\/j.nucmedbio.2020.07.007_bb0195","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1089\/thy.2000.10.321","article-title":"Thyroid iodine transport","volume":"10","author":"Spitzweg","year":"2000","journal-title":"Thyroid"}],"container-title":["Nuclear Medicine and Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0969805120301402?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0969805120301402?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T04:29:02Z","timestamp":1760848142000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0969805120301402"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9]]},"references-count":39,"alternative-id":["S0969805120301402"],"URL":"https:\/\/doi.org\/10.1016\/j.nucmedbio.2020.07.007","relation":{},"ISSN":["0969-8051"],"issn-type":[{"value":"0969-8051","type":"print"}],"subject":[],"published":{"date-parts":[[2020,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Synthesis and characterization of [125I]TZ6544, a promising radioligand for investigating sphingosine-1-phosphate receptor 2","name":"articletitle","label":"Article Title"},{"value":"Nuclear Medicine and Biology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nucmedbio.2020.07.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}